- Home
- RCON vs ANTX Comparison
RCON vs ANTX Comparison
Compare RCON & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- ANTX
- Stock Information
- Founded
- RCON 2007
- ANTX 2017
- Country
- RCON China
- ANTX United States
- Employees
- RCON N/A
- ANTX N/A
- Industry
- RCON Oilfield Services/Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- ANTX Health Care
- Exchange
- RCON Nasdaq
- ANTX Nasdaq
- Market Cap
- RCON 45.3M
- ANTX 38.5M
- IPO Year
- RCON 2009
- ANTX 2022
- Fundamental
- Price
- RCON $1.63
- ANTX $1.25
- Analyst Decision
- RCON
- ANTX Buy
- Analyst Count
- RCON 0
- ANTX 4
- Target Price
- RCON N/A
- ANTX $3.50
- AVG Volume (30 Days)
- RCON 13.4K
- ANTX 54.4K
- Earning Date
- RCON 01-01-0001
- ANTX 05-13-2025
- Dividend Yield
- RCON N/A
- ANTX N/A
- EPS Growth
- RCON N/A
- ANTX N/A
- EPS
- RCON N/A
- ANTX N/A
- Revenue
- RCON $8,996,572.00
- ANTX N/A
- Revenue This Year
- RCON N/A
- ANTX N/A
- Revenue Next Year
- RCON $12.17
- ANTX N/A
- P/E Ratio
- RCON N/A
- ANTX N/A
- Revenue Growth
- RCON N/A
- ANTX N/A
- 52 Week Low
- RCON $1.32
- ANTX $0.87
- 52 Week High
- RCON $3.70
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- RCON 47.36
- ANTX 44.74
- Support Level
- RCON $1.45
- ANTX $1.18
- Resistance Level
- RCON $1.97
- ANTX $1.33
- Average True Range (ATR)
- RCON 0.13
- ANTX 0.08
- MACD
- RCON -0.00
- ANTX -0.00
- Stochastic Oscillator
- RCON 38.60
- ANTX 57.89
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.